keyword
https://read.qxmd.com/read/38690288/self-sufficient-primary-natural-killer-cells-engineered-to-express-t-cell-receptors-and-interleukin-15-exhibit-improved-effector-function-and-persistence
#1
JOURNAL ARTICLE
Els P van Hees, Laura T Morton, Dennis F G Remst, Anne K Wouters, Astrid Van den Eynde, J H Frederik Falkenburg, Mirjam H M Heemskerk
BACKGROUND: NK cells can be genetically engineered to express a transgenic T-cell receptor (TCR). This approach offers an alternative strategy to target heterogenous tumors, as NK:TCR cells can eradicate both tumor cells with high expression of HLA class I and antigen of interest or HLA class I negative tumors. Expansion and survival of NK cells relies on the presence of IL-15. Therefore, autonomous production of IL-15 by NK:TCR cells might improve functional persistence of NK cells. Here we present an optimized NK:TCR product harnessed with a construct encoding for soluble IL-15 (NK:TCR/IL-15), to support their proliferation, persistence and cytotoxic capabilities...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38686388/sars-cov-2-spike-induces-intestinal-barrier-dysfunction-through-the-interaction-between-ceacam5-and-galectin-9
#2
JOURNAL ARTICLE
Yingshu Luo, Zhenling Zhang, Jiangnan Ren, Chunxu Dou, Jiancheng Wen, Yang Yang, Xiaofeng Li, Zhixiang Yan, Yanzhi Han
BACKGROUND: Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5), as a typical tumor marker, has been found to exert immunomodulatory effects in many diseases. We previously reported the clinical and molecular evidences supporting that SARS-Cov-2 infected the gastrointestinal (GI) tract and found a reduction of CEACAM5 in COVID-19 patients' feces which associated with gut dysbiosis. Yet the role of CEACAM5 in GI infection is ill-defined. METHODS: Mice models were established through intraperitoneally injecting with recombinant viral spike-Fc to mimic the intestinal inflammation...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38655616/construction-and-efficacy-testing-of-dna-vaccines-containing-hla-a-02-01-restricted-sars-cov-2-t-cell-epitopes-predicted-by-immunoinformatics
#3
JOURNAL ARTICLE
Dan Tan, Ning Kang, Yuanfei Zhu, Jia Hou, Hanqing Wang, Huijun Xu, Cheng Zu, Zixiang Gao, Mu Liu, Nannan Liu, Qiang Deng, Hongzhou Lu, Jing Liu, Youhua Xie
Vaccines play essential roles in the fight against the COVID-19 pandemic. The development and assessment of COVID-19 vaccines have generally focused on the induction and boosting of neutralizing antibodies targeting the SARS-CoV-2 spike (S) protein. Due to rapid and continuous variation in the S protein, such vaccines need to be regularly updated to match newly emerged dominant variants. T-cell vaccines that target MHC I- or II-restricted epitopes in both structural and non-structural viral proteins have the potential to induce broadly cross-protective and long-lasting responses...
April 24, 2024: Acta Biochimica et Biophysica Sinica
https://read.qxmd.com/read/38558569/novel-aav-variants-with-improved-tropism-for-human-schwann-cells
#4
JOURNAL ARTICLE
Matthieu Drouyer, Tak-Ho Chu, Elodie Labit, Florencia Haase, Renina Gale Navarro, Deborah Nazareth, Nicole Rosin, Jessica Merjane, Suzanne Scott, Marti Cabanes-Creus, Adrian Westhaus, Erhua Zhu, Rajiv Midha, Ian E Alexander, Jeff Biernaskie, Samantha L Ginn, Leszek Lisowski
Gene therapies and associated technologies are transforming biomedical research and enabling novel therapeutic options for patients living with debilitating and incurable genetic disorders. The vector system based on recombinant adeno-associated viral vectors (AAVs) has shown great promise in recent clinical trials for genetic diseases of multiple organs, such as the liver and the nervous system. Despite recent successes toward the development of novel bioengineered AAV variants for improved transduction of primary human tissues and cells, vectors that can efficiently transduce human Schwann cells (hSCs) have yet to be identified...
June 13, 2024: Molecular Therapy. Methods & Clinical Development
https://read.qxmd.com/read/38364929/a-biomaterial-platform-for-t-cell-specific-gene-delivery
#5
JOURNAL ARTICLE
Sharda Pandit, Blake E Smith, Michael E Birnbaum, Yevgeny Brudno
Efficient T cell engineering is central to the success of CAR T cell therapy but involves multiple time-consuming manipulations, including T cell isolation, activation, and transduction. These steps add complexity and delay CAR T cell manufacturing, which takes a mean time of 4 weeks. To streamline T cell engineering, we strategically combine two critical engineering solutions - T cell-specific lentiviral vectors and macroporous scaffolds - that enable T cell activation and transduction in a simple, single step...
February 14, 2024: Acta Biomaterialia
https://read.qxmd.com/read/38277122/impaired-sting-activation-due-to-a-variant-in-the-e3-ubiquitin-ligase-amfr-in-a-patient-with-severe-vzv-infection-and-hemophagocytic-lymphohistiocytosis
#6
JOURNAL ARTICLE
Michelle Mølgaard Thomsen, Morten Kelder Skouboe, Michelle Møhlenberg, Jian Zhao, Kerstin de Keukeleere, Johanna Laura Heinz, Marvin Werner, Anne Kruse Hollensen, Jonas Lønskov, Ian Nielsen, Madalina Elena Carter-Timofte, Baocun Zhang, Jacob Giehm Mikkelsen, Niels Fisker, Søren R Paludan, Kristian Assing, Trine H Mogensen
Varicella zoster virus (VZV) is a neurotropic alphaherpesvirus exclusively infecting humans, causing two distinct pathologies: varicella (chickenpox) upon primary infection and herpes zoster (shingles) following reactivation. In susceptible individuals, VZV can give rise to more severe clinical manifestations, including disseminated infection, pneumonitis, encephalitis, and vasculopathy with stroke. Here, we describe a 3-year-old boy in whom varicella followed a complicated course with thrombocytopenia, hemorrhagic and necrotic lesions, pneumonitis, and intermittent encephalopathy...
January 26, 2024: Journal of Clinical Immunology
https://read.qxmd.com/read/38113461/choosing-the-right-mouse-model-comparison-of-humanized-nsg-and-nbsgw-mice-for-in-vivo-hsc-gene-therapy
#7
JOURNAL ARTICLE
Seunga Choo, Carl B Wolf, Heather M Mack, Mitchell J Egan, Hans-Peter Kiem, Stefan Radtke
In vivo hematopoietic stem cell (HSC) gene therapy is an emerging and promising area of focus in the gene therapy field. Humanized mouse models are frequently used to evaluate novel HSC gene therapy approaches. Here, we comprehensively evaluated two mouse strains, NSG and NBSGW. We studied human HSC engraftment in the bone marrow (BM), mobilization of BM-engrafted HSCs into circulation, in vivo transduction using VSV-G-pseudotyped lentiviral vectors (VSV-G LVs), and the expression levels of surface receptors needed for transduction of viral vectors...
December 19, 2023: Blood Advances
https://read.qxmd.com/read/38070120/a-nonviral-piggybac-transposon-mediated-method-to-generate-large-scale-car-nk-cells-from-human-peripheral-blood-primary-nk-cells
#8
JOURNAL ARTICLE
Zhicheng Du, Tianzhi Zhao, Xianjin Chen, Shijun Zha, Shu Wang
With the inherent antitumor function and unique "off-the-shelf" potential, genetically engineered human natural killer (NK) cells with chimeric antigen receptors (CARs) bear great promise for the treatment of multiple hematological malignancies and solid tumors. Current methods of producing large-scale CAR-NK cells mainly rely on mRNA transfection and viral vector transduction. However, mRNA CAR-NK cells were not stable in CAR expression while viral vector transduction mostly ended up with low efficiency. In this chapter, we described an optimized protocol to generate CAR-NK cells by using the piggyBac transposon system via electroporation and to further expand these engineered CAR-NK cells in a large scale together with artificial antigen-presenting feeder cells...
2024: Methods in Molecular Biology
https://read.qxmd.com/read/38057315/non-coding-rnas-expression-in-sars-cov-2-infection-pathogenesis-clinical-significance-and-therapeutic-targets
#9
REVIEW
Xiaoxing Liu, Wandi Xiong, Maosen Ye, Tangsheng Lu, Kai Yuan, Suhua Chang, Ying Han, Yongxiang Wang, Lin Lu, Yanping Bao
The coronavirus disease 2019 (COVID-19) pandemic has been looming globally for three years, yet the diagnostic and treatment methods for COVID-19 are still undergoing extensive exploration, which holds paramount importance in mitigating future epidemics. Host non-coding RNAs (ncRNAs) display aberrations in the context of COVID-19. Specifically, microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs) exhibit a close association with viral infection and disease progression. In this comprehensive review, an overview was presented of the expression profiles of host ncRNAs following SARS-CoV-2 invasion and of the potential functions in COVID-19 development, encompassing viral invasion, replication, immune response, and multiorgan deficits which include respiratory system, cardiac system, central nervous system, peripheral nervous system as well as long COVID...
December 6, 2023: Signal Transduction and Targeted Therapy
https://read.qxmd.com/read/37886453/selective-rnai-silencing-of-schwann-cell-piezo1-alleviates-mechanical-hypersensitization-following-peripheral-nerve-injury
#10
Brandon Itson-Zoske, Uarda Gani, Alexander Mikesell, Chengsheng Qiu, Fan Fan, Cheryl Stucky, Quinn Hogan, Seung Min Shin, Hongwei Yu
We previously reported functional Piezo1 expression in Schwann cells of the peripheral nervous system. This study is designed to further investigate the role of Schwann cell Piezo1 in peripheral nociception. We first developed an adeno-associated viral (AAV) vector that has primary Schwann cell tropism after delivery into the sciatic nerve. This was achieved by packing AAV-GFP transcribed by a hybrid CMV enhancer/chicken β-actin (CBA) promoter using a capsid AAVolig001 to generate AAVolig001-CBA-GFP. Five weeks after intrasciatic injection of AAVolig001-CBA-GFP in naïve rats, GFP expression was detected selectively in the Schwann cells of the sciatic nerve...
October 16, 2023: Research Square
https://read.qxmd.com/read/37638019/the-janus-face-of-proliferating-plasmablasts-in-dengue-and-covid-19-infections
#11
JOURNAL ARTICLE
Priya Nayak, Kavitha Mukund, Shankar Subramaniam
INTRODUCTION: B cells play an integral role in the immune response to both dengue fever and COVID-19. Prior scRNAseq analyses of peripheral plasmablasts in COVID-19 have revealed a heterogeneous population with distinct cell subsets associated with proliferation; prior studies in patients with dengue fever have likewise shown the presence of proliferative pre-plasmablasts in the circulation. These findings may have implications for disease severity. In this study, we sought to gain a mechanistic understanding of the intracellular processes in naive and memory B cells that are associated with and may lead to an expanded proliferative plasmablast population in the circulation...
2023: Frontiers in Immunology
https://read.qxmd.com/read/37610578/primary-culture-of-the-human-olfactory-neuroepithelium-and-utilization-for-henipavirus-infection-in-vitro
#12
JOURNAL ARTICLE
Mehmet Hakan Ozdener, Barry Rockx, Nancy E Rawson
The olfactory receptor neurons (ORNs) are a unique cell type involved in the initial perception of odors. These specialized epithelial cells are located in the neuroepithelium of the nasal cavities and directly connect the nasal cavity with the central nervous system (CNS) via axons, which traverse the cribriform plate to synapse within the olfactory bulb. ORNs are derived from precursor cells that lie adjacent to the basal lamina of the olfactory epithelium. These precursor cells divide several times and their progeny differentiate into mature sensory neurons throughout life...
2023: Methods in Molecular Biology
https://read.qxmd.com/read/37594575/mir-122-5p-promotes-peripheral-and-central-nervous-system-inflammation-in-a-mouse-model-of-intracerebral-hemorrhage-via-disruption-of-the-mllt1-pi3k-akt-signaling
#13
JOURNAL ARTICLE
Ning Yu, Wenbin Tian, Chao Liu, Pei Zhang, Yinlong Zhao, Chengrui Nan, Qianxu Jin, Xiaopeng Li, Ya Liu
Intracerebral hemorrhage (ICH) is a recognized central nervous system inflammation complication. Several microRNAs (miRNAs or miRs) have been documented to be vital modulators in peripheral and central nervous system inflammation. Based on whole transcriptome sequencing and bioinformatics analysis, this study aims to reveal the possible molecular mechanisms by which miR-122-5p affects the inflammatory response in the peripheral and central nervous system in a mouse model of ICH. Differentially expressed ICH-related miRNAs were screened...
August 18, 2023: Neurochemical Research
https://read.qxmd.com/read/37519407/novel-mutations-in-u-l-24-and-gh-rescue-efficient-infection-of-an-hsv-vector-retargeted-to-trka
#14
JOURNAL ARTICLE
Marco Marzulli, Bonnie L Hall, Mingdi Zhang, William F Goins, Justus B Cohen, Joseph C Glorioso
Transductional targeting of herpes simplex virus (HSV)-based gene therapy vectors offers the potential for improved tissue-specific delivery and can be achieved by modification of the viral entry machinery to incorporate ligands that bind the desired cell surface proteins. The interaction of nerve growth factor (NGF) with tropomyosin receptor kinase A (TrkA) is essential for survival of sensory neurons during development and is involved in chronic pain signaling. We targeted HSV infection to TrkA-bearing cells by replacing the signal peptide and HVEM binding domain of glycoprotein D (gD) with pre-pro-NGF...
September 14, 2023: Molecular Therapy. Methods & Clinical Development
https://read.qxmd.com/read/36817723/aptamer-programmable-adeno-associated-viral-vectors-as-a-novel-platform-for-cell-specific-gene-transfer
#15
JOURNAL ARTICLE
Francesco Puzzo, Chuanling Zhang, Bethany Powell Gray, Feijie Zhang, Bruce A Sullenger, Mark A Kay
Adeno-associated viruses (AAVs) are commonly used for in vivo gene therapy. Nevertheless, the wide tropism that characterizes these vectors limits specific targeting to a particular cell type or tissue. Here, we developed new chemically modified AAV vectors (Nε-AAVs) displaying a single site substitution on the capsid surface for post-production vector engineering through biorthogonal copper-free click chemistry. We were able to identify AAV vectors that would tolerate the unnatural amino acid substitution on the capsid without disrupting their packaging efficiency...
March 14, 2023: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/36755734/evaluating-the-transduction-efficiency-of-systemically-delivered-aav-vectors-in-the-rat-nervous-system
#16
JOURNAL ARTICLE
Olivia J Yang, Gabriella L Robilotto, Firoj Alom, Karla Alemán, Karthik Devulapally, Abigail Morris, Aaron D Mickle
Gene delivery or manipulation with viral vectors is a frequently used tool in basic neuroscience studies. Adeno-associated viruses (AAV) are the most widely used vectors due to their relative safety and long-term efficacy without causing overt immunological complications. Many AAV serotypes have been discovered and engineered that preferentially transduce different populations of neurons. However, efficient targeting of peripheral neurons remains challenging for many researchers, and evaluation of peripheral neuron transduction with AAVs in rats is limited...
2023: Frontiers in Neuroscience
https://read.qxmd.com/read/36604431/neoantigens-promising-targets-for-cancer-therapy
#17
REVIEW
Na Xie, Guobo Shen, Wei Gao, Zhao Huang, Canhua Huang, Li Fu
Recent advances in neoantigen research have accelerated the development and regulatory approval of tumor immunotherapies, including cancer vaccines, adoptive cell therapy and antibody-based therapies, especially for solid tumors. Neoantigens are newly formed antigens generated by tumor cells as a result of various tumor-specific alterations, such as genomic mutation, dysregulated RNA splicing, disordered post-translational modification, and integrated viral open reading frames. Neoantigens are recognized as non-self and trigger an immune response that is not subject to central and peripheral tolerance...
January 6, 2023: Signal Transduction and Targeted Therapy
https://read.qxmd.com/read/36555724/enhancing-motor-and-sensory-axon-regeneration-after-peripheral-nerve-injury-using-bioluminescent-optogenetics
#18
JOURNAL ARTICLE
Anna Ecanow, Ken Berglund, Dario Carrasco, Robin Isaacson, Arthur W English
Introduction-Recovery from peripheral nerve injuries is poor even though injured peripheral axons can regenerate. Novel therapeutic approaches are needed. The most successful preclinical experimental treatments have relied on increasing the activity of the regenerating axons, but the approaches taken are not applicable to many nerve-injured patients. Bioluminescent optogenetics (BL-OG) is a novel method of increasing the excitation of neurons that might be similar to that found with activity-dependent experimental therapies...
December 16, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/36538592/degradation-of-hdac10-by-autophagy-promotes-irf3-mediated-antiviral-innate-immune-responses
#19
JOURNAL ARTICLE
Wenkai Zhou, Jiaming Wang, Xin Wang, Bingjing Wang, Zhehui Zhao, Jie Fu, Yan Wang, Xuan Zhang, Ping Zhu, Minghong Jiang, Xuetao Cao
Histone deacetylases (HDACs) play important roles in immunity and inflammation. Through functional screening, we identified HDAC10 as an inhibitor of the type I interferon (IFN) response mediated by interferon regulatory factor 3 (IRF3). HDAC10 abundance was decreased in mouse macrophages in response to innate immune stimuli and was reduced in peripheral blood mononuclear cells (PBMCs) from patients with systemic lupus erythematosus (SLE) compared with that in PBMCs from healthy donors. Deficiency in HDAC10 in mouse embryonic fibroblasts and in mice promoted the expression of genes encoding type I IFNs and of IFN-stimulated genes (ISGs), leading to enhanced antiviral responses in vitro and in vivo...
December 20, 2022: Science Signaling
https://read.qxmd.com/read/36440989/small-interfering-rna-delivery-into-primary-human-natural-killer-cells-for-functional-gene-analyses
#20
JOURNAL ARTICLE
Pouria Momayyezi, Karl-Johan Malmberg, Quirin Hammer
Studying gene functions in human natural killer (NK) cells is key for advancing the understanding of NK cell biology and holds promise to pave the way for improving NK cell therapies against cancer. However, NK cells are challenging to manipulate, and investigation of gene functions in NK cells is hampered by variable delivery efficiencies and impaired viability upon electroporation, lipofection, or viral transduction. Here, we report a simple workflow for delivery of commercially available small interfering RNA molecules into primary human NK cells to enable functional gene analyses...
November 2022: Current protocols
keyword
keyword
67777
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.